AI-generated analysis. Always verify with the original filing.
Myx, Inc., a Wyoming corporation founded on February 25, 2025, is developing Legal Stage, a bilingual web-based platform providing educational and informational tools for legal, operational, and business navigation in the performing arts sector, targeting cross-border U.S.-China theatrical collaborations with features like contract templates, legal academy, and access to independent professionals without providing legal advice. The company has generated limited revenue of $2,184 for the fiscal year ended May 31, 2025, and $14,229 for the six months ended November 30, 2025, with a net loss of $99,083 and net income of $3,031 respectively, operating with no cash on hand, total assets of $85,544 as of November 30, 2025, and an accumulated deficit of $96,052, raising substantial going concern doubts. Myx is registering 9,000,000 shares of common stock at $0.02 per share in a self-underwritten best-efforts offering aiming for up to $180,000 gross proceeds over 270 days, intending to list on OTCQB, with current 5,000,000 shares outstanding where CEO Tatyana Muyingo holds 80%. Proceeds will fund platform development, marketing, G&A, compliance, and working capital, with a minimum $45,000 needed for 12-month operations including office lease, staff, and app development. The company goes public to raise essential capital for commercialization post-beta launch, addressing liquidity constraints amid development-stage risks, regulatory UPL concerns, competition, and CEO control.
Offering Amount
$180.0K
Shares Offered
90,000,000
Price Range
$0.02 – $0.02
Shares Offered
9,000,000
Offering Amount
$180,000
Price Range
$0.02
Share Type
Common Stock
Use of Proceeds: Platform development, marketing & client acquisition, general & administrative, legal/accounting/compliance, contingency/working capital
Myx, Inc. is developing a web-based platform that provides educational and informational tools for legal, operational, and business navigation within the performing arts sector.